BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29649594)

  • 1. Detection of human parvovirus B19 infection in the thymus of patients with thymic hyperplasia-associated myasthenia gravis.
    Gong L; Li Y; Li X; Tu Q; Mou X; Wang S; Wan Y; Lu Q; Wang J; Zhang W; Zhu S; Han X; Yao L; Zhang J; Huang G; Zhang W
    Clin Microbiol Infect; 2019 Jan; 25(1):109.e7-109.e12. PubMed ID: 29649594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Parvovirus B19 May Be a Risk Factor in Myasthenia Gravis with Thymoma.
    Gong L; Tian J; Zhang Y; Feng Z; Wang Q; Wang Y; Zhang F; Zhang W; Huang G
    Ann Surg Oncol; 2023 Mar; 30(3):1646-1655. PubMed ID: 36509875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological Findings in Myasthenia Gravis Patients with Thymic Hyperplasia and Thymoma.
    Chen P; Wang YP; Mou DL; Li ZY; Qu QM; Wang HY; Deng Y; Li XF; Wang T; Xu XH; Zhao G
    Pathol Oncol Res; 2018 Jan; 24(1):67-74. PubMed ID: 28299711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymic hyperplasia and neoplasia: a review of current concepts.
    Levine GD; Rosai J
    Hum Pathol; 1978 Sep; 9(5):495-515. PubMed ID: 361541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic Lesions in Myasthenia Gravis: A Clinicopathological Study from India.
    Nishadham V; Bardhan M; Polavarapu K; Vengalil S; Nashi S; Menon D; Ganaraja VH; Preethish-Kumar V; Valasani RK; Huddar A; Unnikrishnan GK; Thomas A; Saravanan A; Kulanthaivelu K; Nalini A; Nandeesh BN
    J Neuromuscul Dis; 2022; 9(3):411-422. PubMed ID: 35431258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymic diseases as revealed by a series of consecutive thymectomies and biopsies from the thymus.
    Sundström C
    Ups J Med Sci; 1976; 81(1):18-22. PubMed ID: 1273995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymus in myasthenia gravis: comparison of CT and pathologic findings and clinical outcome after thymectomy.
    Nicolaou S; Müller NL; Li DK; Oger JJ
    Radiology; 1996 Nov; 201(2):471-4. PubMed ID: 8888243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of Bcl-2 protein in the myasthenic thymus.
    Onodera J; Nakamura S; Nagano I; tobita M; Yoshioka M; Takeda A; Oouchi M; Itoyama Y
    Ann Neurol; 1996 Apr; 39(4):521-8. PubMed ID: 8619530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of TNF-related apoptosis-inducing ligand and receptors and implications in thymus biology and myasthenia gravis.
    Kanatli I; Akkaya B; Uysal H; Kahraman S; Sanlioglu AD
    Neuromuscul Disord; 2017 Feb; 27(2):128-135. PubMed ID: 28012741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of thymus in myasthenia gravis: from thymic hyperplasia to thymic tumor.
    Priola AM; Priola SM
    Clin Radiol; 2014 May; 69(5):e230-45. PubMed ID: 24581970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Computed tomography of the mediastinum in myasthenia gravis. Normal findings, thymic hyperplasia, thymomas (author's transl)].
    Gürtler KF; Janzen RW; Hagemann J; Otto HF
    Rofo; 1982 Jan; 136(1):35-40. PubMed ID: 6212407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the malignant grade of thymoma by morphometric analysis.
    Nomori H; Horinouchi H; Kaseda S; Ishihara T; Torikata C
    Cancer; 1988 Mar; 61(5):982-8. PubMed ID: 3338061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of thymomas in the development of myasthenia gravis.
    Marx A; Müller-Hermelink HK; Ströbel P
    Ann N Y Acad Sci; 2003 Sep; 998():223-36. PubMed ID: 14592880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic and high CXCL13 chemokine expression in myasthenia gravis with thymic lymphoid hyperplasia.
    Shiao YM; Lee CC; Hsu YH; Huang SF; Lin CY; Li LH; Fann CS; Tsai CY; Tsai SF; Chiu HC
    J Neuroimmunol; 2010 Apr; 221(1-2):101-6. PubMed ID: 20223524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymus involvement in early-onset myasthenia gravis.
    Cron MA; Maillard S; Villegas J; Truffault F; Sudres M; Dragin N; Berrih-Aknin S; Le Panse R
    Ann N Y Acad Sci; 2018 Jan; 1412(1):137-145. PubMed ID: 29125185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thymus gland scan in myasthenia gravis: experience in 52 patients].
    Testa G; Angelini C; Tatto I; Ravasini R
    Riv Patol Nerv Ment; 1978; 99(4):244-54. PubMed ID: 752184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphologic criteria for the diagnosis of thymic pathology in myasthenia].
    Rykov VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(7):73-8. PubMed ID: 7124229
    [No Abstract]   [Full Text] [Related]  

  • 18. Morphological imaging of thymic disorders.
    Camera L; Brunetti A; Romano M; Larobina M; Marano I; Salvatore M
    Ann Med; 1999 Oct; 31 Suppl 2():57-62. PubMed ID: 10574157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of receptor for advanced glycation end-products (RAGE) in thymus from myasthenia patients.
    Bouchikh M; Zouaidia F; Benhaddou EHA; Mahassini N; Achir A; El Malki HO
    Rev Neurol (Paris); 2017 Jun; 173(6):388-395. PubMed ID: 28461027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.